PCIB.OL Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 11:28):

Stats
Dzisiejszy wolumen	128 523
Średni wolumen	76 640.00
Kapitalizacja rynkowa	58.15M
EPS	NOK0 ( 2024-02-14 )
Następna data zysków	( NOK0 ) 2024-05-09
Last Dividend	NOK0 ( N/A )
Next Dividend	NOK0 ( N/A )
P/E	-1.970
ATR14	NOK0.0330 (2.12%)

PCI Biotech Holding ASA Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PCI Biotech Holding ASA Finanse

Annual	2023
Przychody:	NOK0
Zysk brutto:	NOK-371 000 (0.00 %)
EPS:	NOK-0.540

FY	2023
Przychody:	NOK0
Zysk brutto:	NOK-371 000 (0.00 %)
EPS:	NOK-0.540

FY	2022
Przychody:	NOK0
Zysk brutto:	NOK-633 000 (0.00 %)
EPS:	NOK-1.440

FY	2021
Przychody:	NOK0.00
Zysk brutto:	NOK0.00 (0.00 %)
EPS:	NOK-0.843

Financial Reports:

No articles found.

PCI Biotech Holding ASA

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.